Fibrosis after gynaecomastia surgery is a recognised complication that can cause persistent firmness, contour irregularities, and skin tethering beneath the chest wall. As part of the body's natural wound-healing response, collagen deposition following glandular excision or liposuction can occasionally become excessive or disorganised. Understanding why fibrosis develops, how to recognise it, and what treatment options are available — both on the NHS and privately — helps patients set realistic expectations and seek timely advice when needed. This article covers the full picture, from causes and symptoms through to recovery timelines and when to consult a clinician.

Why Fibrosis Develops After Gynaecomastia Surgery

Fibrosis develops when the wound-healing cascade triggers excessive or disorganised collagen deposition in tissue planes disrupted during glandular excision or liposuction, producing firm, irregular subcutaneous tissue beneath the chest wall.

Fibrosis is a natural part of the body's healing response following any surgical procedure, including gynaecomastia surgery (also known as male breast reduction). When tissue is incised, excised, or disrupted — whether through glandular excision, liposuction, or a combination of both — the body initiates a wound-healing cascade. This involves the proliferation of fibroblasts, which lay down collagen fibres to repair the damaged area. In most cases, this process resolves without complication, leaving minimal scarring. However, in some individuals, collagen deposition becomes excessive or disorganised, resulting in fibrotic tissue that feels firm, irregular, or tethered beneath the skin.

It is helpful to distinguish between two types of post-surgical scarring. Hypertrophic or keloid scars are raised, thickened changes within the dermis (the skin itself) and are visible at the surface. Deeper subcutaneous fibrosis, by contrast, forms beneath the skin in the tissue planes disrupted during surgery, and may cause firmness, contour irregularities, or tethering without a prominent surface scar. These two processes have different characteristics and respond differently to treatment.

Several factors can increase the likelihood of significant fibrosis developing after gynaecomastia surgery. These include:

• Surgical technique: Aggressive liposuction or extensive glandular excision can cause greater tissue trauma, increasing fibrotic risk.

• Individual healing biology: Genetic predisposition plays a role; some patients are naturally prone to hypertrophic scarring or keloid formation.

• Post-operative haematoma or seroma: Fluid collections that are not promptly managed can organise into fibrous tissue over time. A rapidly expanding haematoma in the early post-operative period is an urgent complication requiring same-day contact with the surgical team.

• Infection: Even low-grade post-operative infection can stimulate excessive collagen production.

• Factors impairing wound healing: Smoking, poorly controlled diabetes, and poor nutritional status are all recognised risk factors for impaired healing and increased scarring. Patients are strongly advised to stop smoking before and after surgery; NHS Stop Smoking Services (www.nhs.uk/better-health/quit-smoking) can provide support.

• Inadequate compression garment use: Compression garments are standard practice following gynaecomastia surgery and are commonly recommended to support tissue remodelling, though evidence specifically for preventing deep subcutaneous fibrosis is limited.

The chest wall's contoured anatomy makes fibrosis particularly noticeable in this region. Uneven fibrous bands can create visible contour irregularities, puckering, or a hardened feel that patients may find distressing. Understanding why fibrosis occurs is the first step towards managing it effectively and setting realistic expectations for recovery.

Recognising the Signs and Symptoms of Post-Surgical Fibrosis

Key signs include persistent firmness around the areola or incision lines beyond six to eight weeks, visible contour irregularities, skin tethering, and reduced skin mobility that does not resolve as swelling subsides.

Following gynaecomastia surgery, a degree of swelling, bruising, and firmness is entirely expected in the first few weeks. Distinguishing normal post-operative changes from developing fibrosis can be challenging, but there are specific signs that suggest fibrotic tissue is forming rather than simply resolving oedema.

Common signs of post-surgical fibrosis include:

• Persistent firmness or hardness beneath the skin, particularly around the areola or along the incision lines, that does not soften after six to eight weeks

• Visible contour irregularities, such as lumps, ridges, or indentations that become more apparent as swelling subsides

• Skin tethering or puckering, where the overlying skin appears to be pulled inward by underlying scar tissue

• Reduced skin mobility over the chest, making the tissue feel bound or restricted

• Mild discomfort or sensitivity in the affected area, which may persist beyond the expected recovery window

Some degree of firmness is normal for up to three to six months post-operatively, as the remodelling phase of wound healing continues throughout this period. Fibrosis becomes a clinical concern when these features persist beyond six months, worsen over time, or are accompanied by significant asymmetry or functional discomfort.

In rare cases, fibrotic changes may mimic other conditions, including recurrent gynaecomastia or, very rarely, an underlying breast pathology. Any new or worsening lump in the chest following surgery should therefore be assessed by a clinician.

GPs should follow NICE guideline NG12 (Suspected cancer: recognition and referral) when assessing breast symptoms in male patients:

• Aged 30 or over with an unexplained breast lump: refer urgently via the suspected cancer pathway (2-week wait).

• Under 30 with an unexplained breast lump: consider a non-urgent referral, using clinical judgement.

• At any age, urgent referral is appropriate if there are suspicious features, including a hard, irregular, or fixed lump; skin changes suggestive of malignancy; axillary lymphadenopathy; unilateral nipple inversion; or unilateral bloody nipple discharge.

Where benign causes are considered likely, a GP may arrange an ultrasound directly. Patients should feel empowered to seek advice promptly, as early assessment leads to better outcomes.

Treatment Options Available on the NHS and Privately

First-line treatment is conservative, including compression garments and scar massage; intralesional corticosteroid injections or surgical revision are reserved for persistent or significant fibrosis, with NHS funding subject to local ICB criteria.

The management of fibrosis after gynaecomastia surgery depends on its severity, duration, and impact on the patient's quality of life. Mild fibrosis that causes no significant cosmetic or functional concern may require no active treatment beyond reassurance and time. Where fibrosis is persistent, symptomatic, or causing notable contour irregularities, a range of treatment options are available.

Conservative and non-surgical approaches are typically the first line of management:

• Compression garments: Continued or renewed use of a well-fitted compression vest is standard practice following gynaecomastia surgery. Evidence for preventing or remodelling deep subcutaneous fibrosis specifically is limited, but compression is widely recommended to support tissue settling and reduce swelling.

• Massage therapy: Gentle scar massage, once wounds are fully healed (usually after six weeks), may help improve superficial tissue pliability and reduce adhesions. A physiotherapist or specialist scar therapist can advise on technique. Evidence is largely based on clinical experience and is most applicable to surface scarring.

• Silicone gel sheets or topical silicone: These have reasonable evidence supporting their use in reducing hypertrophic and keloid dermal scarring (raised surface scars). They are not established treatments for deeper subcutaneous fibrosis, and patients should be aware of this distinction when considering their use.

• Therapeutic ultrasound: Delivered by a physiotherapist, this may be offered as an adjunct to other treatments. Evidence for softening deep post-surgical fibrosis is limited and of low quality; it is not a standard NHS treatment for this indication. Any decision to pursue it should involve shared decision-making and consideration of local availability.

Medical and procedural interventions may be considered for more established or resistant fibrosis:

• Intralesional corticosteroid injections (e.g., triamcinolone acetonide, such as Kenalog): These are used by dermatologists and plastic surgeons to reduce collagen overproduction in hypertrophic and keloid scars, which is the licensed indication per the UK Summary of Product Characteristics (SmPC). Their use for deeper subcutaneous fibrosis following gynaecomastia surgery may be considered off-label, and patients should discuss this with their specialist. Potential adverse effects include localised skin atrophy, hypopigmentation, telangiectasia, pain at the injection site, and, rarely, infection. Administration should be by a trained specialist. Patients who experience suspected adverse effects from any medicine should report these via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

• Surgical revision: In cases of significant contour deformity caused by fibrotic bands or irregular scarring, surgical revision may be appropriate. This is generally considered only after fibrosis has fully matured, usually at 12 to 18 months post-operatively, to allow for natural resolution.

NHS funding for revision surgery following cosmetic procedures varies by local Integrated Care Board (ICB) policy and is typically restricted to cases where there is a demonstrable functional impairment or significant psychological impact meeting specific clinical thresholds. Patients should check their local ICB criteria, as provision is not uniform across England. Private surgical revision remains an option for those who do not meet NHS criteria. BAPRAS (British Association of Plastic, Reconstructive and Aesthetic Surgeons) and BAAPS (British Association of Aesthetic Plastic Surgeons) provide patient information on complications and aftercare that may be helpful when considering options.

Recovery Expectations and Long-Term Outcomes

Most fibrotic firmness and minor contour irregularities resolve within six to twelve months as the remodelling phase progresses; a small proportion of patients require active intervention or surgical revision.

Understanding the typical recovery timeline after gynaecomastia surgery helps patients contextualise their experience of fibrosis and avoid unnecessary anxiety. The healing process occurs in distinct phases: the inflammatory phase (days one to five), the proliferative phase (weeks one to six), and the remodelling phase, which can last from six months to two years. Fibrosis, when it occurs, most commonly becomes apparent during the proliferative and early remodelling phases, as collagen deposition peaks.

For the majority of patients, fibrotic changes that develop after gynaecomastia surgery will gradually soften and improve over time without intervention. Clinical experience and published literature suggest that:

• Most firmness and minor contour irregularities resolve within six to twelve months as the remodelling phase progresses and collagen fibres reorganise.

• Patients who follow post-operative instructions carefully — including consistent compression garment use, avoiding strenuous activity during early recovery, and attending follow-up appointments — tend to experience better long-term outcomes.

• Smoking significantly impairs wound healing and increases fibrotic risk; patients are strongly advised to stop smoking before and after surgery. Support is available through NHS Stop Smoking Services (www.nhs.uk/better-health/quit-smoking).

Long-term outcomes following gynaecomastia surgery are generally positive, with satisfaction rates reported favourably in the surgical literature, though patients should discuss realistic expectations with their surgical team before proceeding. A small proportion of patients will develop clinically significant fibrosis that requires active management or surgical revision.

It is also important to distinguish fibrosis from recurrent gynaecomastia. New glandular enlargement or nipple tenderness developing after surgery may suggest recurrence related to hormonal changes, weight gain, or certain medicines (such as anabolic steroids, some antipsychotics, or spironolactone), rather than fibrosis. If this is suspected, a GP review is appropriate and may include consideration of endocrine assessment.

Not sure if this is normal? Chat with one of our pharmacists →

Patients should be encouraged to maintain realistic expectations and to engage openly with their surgical team throughout recovery. Psychological support may be beneficial for those who find the recovery process distressing, and referral to a counsellor or clinical psychologist can be arranged through a GP if needed.

When to Seek Further Medical Advice After Gynaecomastia Surgery

Patients should seek same-day urgent care for a rapidly expanding haematoma or signs of infection, and contact their GP or surgical team for any new persistent lump, worsening asymmetry, or psychological distress related to recovery.

Whilst fibrosis is a recognised and manageable complication of gynaecomastia surgery, there are specific circumstances in which patients should seek prompt medical advice rather than waiting for natural resolution. Knowing when to contact a GP or return to the surgical team is an important aspect of safe post-operative care.

Contact your surgical team the same day, or seek urgent care via NHS 111 or your nearest Emergency Department if you cannot reach them, if you experience:

• A rapidly expanding swelling or haematoma (blood collection) in the early post-operative period — this may require urgent surgical review

• Signs of infection, including increasing redness, warmth, swelling, discharge from the wound, or fever — these require timely assessment and may need antibiotic treatment

Contact your GP or surgical team if you experience:

• A new, persistent, or unusually hard lump in the chest that was not present immediately after surgery — this warrants clinical assessment to exclude recurrent gynaecomastia, seroma, haematoma, or, in rare cases, an underlying breast pathology

• Significant asymmetry that worsens rather than improves over time, particularly if accompanied by skin changes

• Persistent pain or discomfort beyond the expected recovery period that is not responding to simple analgesia

• Psychological distress related to the appearance of the chest or the recovery process, which may benefit from professional support

For patients who had their surgery performed privately, the first point of contact should be the operating surgeon or their clinical team. If this is not possible, or if the surgery was performed abroad, a GP can assess the concern and refer appropriately.

GPs should apply NICE guideline NG12 when assessing breast symptoms in male patients:

• Aged 30 or over with an unexplained breast lump: refer urgently via the suspected cancer pathway (2-week wait).

• Under 30 with an unexplained breast lump: consider a non-urgent referral, using clinical judgement.

• At any age, urgent referral is appropriate for suspicious features, including a hard, irregular, or fixed lump; skin changes suggestive of malignancy; axillary lymphadenopathy; unilateral nipple inversion; or unilateral bloody nipple discharge.

Patients should feel empowered to seek advice without delay. If you are unsure whether your symptoms require urgent attention and cannot reach your surgical team, NHS 111 (online at 111.nhs.uk or by telephone) can provide guidance on the appropriate next step.

Frequently Asked Questions